Sun Pharma
-
-
-
-
-
Sun Pharma and Zydus to co-market innovative CKD treatment drug in India
INDIA – Sun Pharma has partnered with Zydus Lifesciences Limited to co-market an innovative chronic kidney disease (CKD) treatment drug, Desidustat, in India. Desidustat, a…
-
Sun Pharma set to commercialize Pharmazz’s innovative stroke drug Tyvalzi in India
INDIA – Sun Pharma and Pharmazz Inc., a biopharmaceutical company based in the United States, have signed an exclusive license agreement to bring a first-in-class…
-
Sun Pharma to commercially launch Philogen’s skin cancer drug in Europe, Australia & New Zealand
INDIA – Sun Pharma is set to begin the commercialization of novel skin cancer drug, Nidlegy, across the territories of Europe, Australia, and New Zealand…
-
Sun Pharma to acquire controlling stake in Taro, appoints new Directors
INDIA – Sun Pharma has signed a definitive agreement to acquire a controlling stake in Taro Pharmaceutical Industries, an Israeli research-based pharmaceutical manufacturer, in a…
-
Sun Pharma introduces CEQUA to treat dry eye disease in India
INDIA – Sun Pharma, through its wholly-owned subsidiary, has commercially launched CEQUA, a novel ophthalmology treatment, delivered with nanomicellar (NCELL) technology in India. This news…
-
Sun Pharma’s acquisition of Concert fuels hopes of deuruxolitinib push to FDA Drug Review
INDIA – Sun Pharma has wrapped up the acquisition of Concert Pharmaceuticals Inc. (Concert) with the desire to accelerate the market entry of deuruxolitinib, a…